# BIOFORCE NANOSCIENCES HOLDINGS, INC.

BIOFORCE NANOSCIENCES HOLDINGS, INC. is a public company listed on OTC as BFNH, headquartered in Virginia Beach, VA, United States.

## Company overview

- **Legal name:** BIOFORCE NANOSCIENCES HOLDINGS, INC.
- **Former names in filing history:** SILVER RIVER VENTURES, INC. (2004-12-14 to 2006-02-24)
- **Classification:** Public company
- **Industry (SIC):** 3826 — Laboratory Analytical Instruments
- **Headquarters:** Virginia Beach, VA, United States
- **Fiscal year end:** December 31
- **Ticker:** OTC: BFNH
- **SEC CIK:** 0001310488

## About

BIOFORCE NANOSCIENCES HOLDINGS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001310488, and its reported industry is Laboratory Analytical Instruments. In 10-K filed on 2026-04-15, it reported net income of USD -1,291,951; total assets of USD 786 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Net income:** -$1.3M (USD -1,291,951)
- **Total assets:** $786 (USD 786)
- **Cash and equivalents:** $786 (USD 786)
- **Operating cash flow:** -$65,150 (USD -65,150)

### FY2024 (period ended 2024-12-31)

- **Net income:** -$490,437 (USD -490,437)
- **Total assets:** $862 (USD 862)
- **Cash and equivalents:** $862 (USD 862)
- **Operating cash flow:** -$61,250 (USD -61,250)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$471,953 (USD -471,953)
- **Total assets:** $638 (USD 638)
- **Cash and equivalents:** $638 (USD 638)
- **Operating cash flow:** -$46,702 (USD -46,702)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$485,514 (USD -485,514)
- **Total assets:** $734 (USD 734)
- **Cash and equivalents:** $734 (USD 734)
- **Operating cash flow:** -$68,389 (USD -68,389)

## Recent SEC filings

- Form 8-K — filed 2026-10-07 — period 2026-10-02 — CURRENT REPORT
- Form 8-K — filed 2026-09-04 — period 2026-08-31 — CURRENT REPORT
- Form 8-K — filed 2026-08-18 — period 2026-08-17 — CURRENT REPORT
- Form 8-K — filed 2026-08-14 — period 2026-08-14 — CURRENT REPORT
- Form 10-Q — filed 2026-08-10 — period 2026-06-30 — QTR. REPORT - JUNE 30, 2026
- Form 8-K — filed 2026-07-07 — period 2026-07-01 — CURRENT REPORT
- Form 8-K — filed 2026-07-01 — period 2026-06-05 — CURRENT REPOT
- Form 8-K — filed 2026-06-18 — period 2026-04-15 — CURRENT REPORT
- Form 10-Q — filed 2026-05-19 — period 2026-03-31 — QTR. REPORT - MARCH 31, 2026
- Form 10-K — filed 2026-04-15 — period 2025-12-31 — YEAR- END REPORT - DEC. 31, 2025
- Form 10-Q — filed 2025-11-19 — period 2025-09-30 — QTR. REPORT - SEPTEMBER 30, 2025
- Form 10-Q — filed 2025-08-11 — period 2025-06-30 — QTR. REPORT - JUNE 30, 2025

---

Updated: 2026-10-23T06:52:41Z

Canonical page: https://altss.com/profile/bioforce-nanosciences-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology